A detailed history of New York State Common Retirement Fund transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 59,515 shares of TGTX stock, worth $1.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59,515
Previous 56,169 5.96%
Holding current value
$1.91 Million
Previous $999,000 39.34%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$17.21 - $25.28 $57,584 - $84,586
3,346 Added 5.96%
59,515 $1.39 Million
Q2 2024

Jul 31, 2024

BUY
$13.32 - $19.19 $239 - $345
18 Added 0.03%
56,169 $999,000
Q1 2024

May 07, 2024

SELL
$13.02 - $21.3 $742 - $1,214
-57 Reduced 0.1%
56,151 $854,000
Q4 2023

Feb 01, 2024

BUY
$6.68 - $18.81 $4,428 - $12,471
663 Added 1.19%
56,208 $960,000
Q3 2023

Nov 07, 2023

SELL
$8.36 - $26.5 $634,808 - $2.01 Million
-75,934 Reduced 57.75%
55,545 $464,000
Q2 2023

Aug 07, 2023

BUY
$15.48 - $35.0 $952,670 - $2.15 Million
61,542 Added 88.0%
131,479 $3.27 Million
Q1 2023

May 02, 2023

SELL
$10.23 - $19.34 $230,318 - $435,420
-22,514 Reduced 24.35%
69,937 $1.05 Million
Q4 2022

Jan 30, 2023

SELL
$5.01 - $11.83 $420 - $993
-84 Reduced 0.09%
92,451 $1.09 Million
Q3 2022

Nov 08, 2022

BUY
$4.57 - $8.4 $1,466 - $2,696
321 Added 0.35%
92,535 $548,000
Q2 2022

Aug 04, 2022

SELL
$3.74 - $10.66 $665 - $1,897
-178 Reduced 0.19%
92,214 $392,000
Q1 2022

May 05, 2022

SELL
$7.81 - $20.45 $1,585 - $4,151
-203 Reduced 0.22%
92,392 $879,000
Q4 2021

Feb 02, 2022

SELL
$15.2 - $35.51 $567,051 - $1.32 Million
-37,306 Reduced 28.72%
92,595 $1.76 Million
Q3 2021

Nov 02, 2021

SELL
$21.78 - $40.45 $526,313 - $977,474
-24,165 Reduced 15.68%
129,901 $4.32 Million
Q2 2021

Aug 02, 2021

BUY
$32.5 - $48.96 $937,202 - $1.41 Million
28,837 Added 23.03%
154,066 $5.98 Million
Q1 2021

May 11, 2021

SELL
$41.61 - $54.3 $469,735 - $612,992
-11,289 Reduced 8.27%
125,229 $6.04 Million
Q4 2020

Feb 08, 2021

BUY
$25.27 - $54.9 $1.06 Million - $2.31 Million
42,018 Added 44.46%
136,518 $7.1 Million
Q3 2020

Nov 05, 2020

BUY
$18.49 - $27.24 $110,939 - $163,440
6,000 Added 6.78%
94,500 $2.53 Million
Q2 2020

Aug 07, 2020

BUY
$8.9 - $21.84 $97,900 - $240,240
11,000 Added 14.19%
88,500 $1.72 Million
Q4 2019

Feb 05, 2020

SELL
$5.1 - $11.2 $15,299 - $33,600
-3,000 Reduced 3.73%
77,500 $860,000
Q3 2019

Nov 07, 2019

SELL
$5.38 - $8.99 $538 - $899
-100 Reduced 0.12%
80,500 $452,000
Q2 2019

Aug 09, 2019

BUY
$6.27 - $8.65 $109,724 - $151,375
17,500 Added 27.73%
80,600 $697,000
Q1 2019

May 08, 2019

BUY
$4.02 - $8.04 $68,741 - $137,483
17,100 Added 37.17%
63,100 $507,000
Q4 2018

Feb 08, 2019

SELL
$3.44 - $5.76 $68,112 - $114,048
-19,800 Reduced 30.09%
46,000 $189,000
Q2 2018

Aug 10, 2018

SELL
$12.5 - $15.0 $473,162 - $567,795
-37,853 Reduced 36.52%
65,800 $865,000
Q1 2018

May 10, 2018

BUY
$8.7 - $16.8 $6,959 - $13,440
800 Added 0.78%
103,653 $1.47 Million
Q2 2017

Aug 11, 2017

BUY
N/A
102,853
102,853 $1.03 Million

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.67B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.